Claris Lifesciences Update by Epic Research

Claris Lifesciences has received a report from US Food and Drug Administration (USFDA) for the inspection it conducted classifying the finished dosage plant and API plant as acceptable.







Real Time News & Trading Trends Keep Liking Epic Research Private Limited



Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips